A Wyss Center spin-off transforming brain surgery
Forging a new era of highly targeted neuro therapies
Clee Medical SA is a pioneering neurotechnology company specializing in ultra-high-resolution intraoperative imaging combined with AI-powered navigation to enhance minimally invasive brain surgery. Founded in December 2024, the company emerged from the Minimally Invasive Intracranial Access (MICA) research project, hosted by the Wyss Center from 2021 to 2024.
Clee Medical’s technology addresses critical challenges in neurosurgical procedures by delivering real-time, ultra-high-resolution imaging to guide surgeons with unmatched precision. Leveraging artificial intelligence and machine learning, the system enables the detection of intricate neuroanatomy and vasculature, ensuring safe and targeted access to delicate areas of the brain. This solution represents a significant leap in the accuracy and efficiency of neurosurgical interventions.
“Overcoming inefficiencies in neurosurgery is key to accelerating neurotech adoption and improving patient outcomes. Our mission is to redefine neuro-intervention with safer, faster, and more scalable solutions, unlocking a new era of targeted therapies.”
“Clee Medical not only holds the promise of improving patient outcomes but also highlights the Wyss Center’s dedication to bridging the gap between scientific discovery and real-world impact.”
